The european radiotherapy patient positioning market is on the brink of substantial expansion, with projections indicating a rise from USD 135.1 million in 2024 to USD 196.1 million by 2034. This growth translates to a compound annual growth rate (CAGR) of 3.8% over the forecast period, reflecting a burgeoning demand for advanced patient positioning systems that are crucial for effective cancer treatment.
Over the past decade, the global surge in cancer cases has significantly heightened the need for precise and reliable patient positioning during radiotherapy. The effectiveness of radiation therapy hinges on the accurate delivery of treatment while minimizing exposure to surrounding healthy tissues. Consequently, radiation therapy centers across Europe are increasingly integrating these advanced positioning systems to enhance treatment outcomes and bolster patient safety.
In parallel, the vascular patches industry has also demonstrated notable growth, with revenue reaching USD 130.1 million in 2023 and a projected year-over-year increase of 3.9% in 2024. This trend highlights the broader expansion of medical device markets, fueled by technological advancements and rising healthcare demands.
The growing emphasis on innovation within radiotherapy patient positioning tools—including 3D imaging, real-time tracking, and robotic devices—is a key driver of market expansion. These sophisticated technologies enhance alignment precision and ensure consistency in radiation dosing, ultimately improving treatment efficacy and patient outcomes.
As the demand for cutting-edge radiotherapy solutions continues to escalate, the European market for patient positioning systems is poised for sustained growth, driven by technological advancements and an increasing focus on personalized cancer care.
“To conduct an in-depth analysis of the radiotherapy patient positioning market in Europe, focusing on current trends, competitive landscape, and key drivers of growth,” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).
Key Takeaways: Europe Radiotherapy Patient Positioning Market
- The European radiotherapy patient positioning market is projected to experience a consistent growth rate of 3.8% from 2024 to 2034.
- The market value is anticipated to reach USD 196.1 million by 2034, up from USD 135.1 million in 2024.
- The German market is expected to grow at a CAGR of 1.9%, driven by factors such as precision medicine and an aging population.
- Italy’s market is anticipated to grow at a CAGR of 2.9%, fueled by advancements in radiotherapy technologies and improved survival rates.
- France is forecasted to exhibit a CAGR of 3.2%, benefiting from increased investments in healthcare and radiotherapy.
- The growing focus on precision medicine is driving demand for advanced radiotherapy techniques.
- The increasing elderly population, particularly those aged 60 and above, is a significant factor in market expansion.
- Advancements in radiotherapy, such as 3D techniques, are leading to higher survival rates for cancer patients.
Find the Latest Updates on Get Old Source Reports
Competitive Landscape:
The leading players in the radiotherapy patient positioning market are significantly investing in research and development to drive innovation in products such as fiducial markers, vaginal markers, and rectal markers. Their efforts are aimed not only at enhancing the effectiveness of these products but also at strengthening their portfolios through strategic partnerships and expanding their presence in the European market.
Recent Industry Developments in Radiotherapy Patient Positioning Market:
- March 2022: Elekta announced a collaboration with IBA to enhance quality assurance (QA) solutions.
- June 2020: Mevion Medical Systems partnered with Orfit Industries, confirming that the Aerial Couch Top is compatible with MEVION S250 Series Proton Therapy Systems.
Key Players of Radiotherapy Patient Positioning Industry:
- CARITAS
- Orfit Industries
- Qfix
- Elekta
- Eckert & Ziegler BEBIG
- CDR Systems
- Roper Technologies-CIVCO
- Best Medical Canada
- Blessing Cathay Corporation
- Candor ApS
- IZI Medical Products
- Klarity Medical Products
- MacroMedics BV
- OSL Oncology Systems Limited.
- T-Tape Company B.V.
Key Segments of Radiotherapy Patient Positioning Industry:
By Product:
In terms of product, the industry is divided into thermoplastic masks & sheets (head masks, head & shoulder masks and torso & extremities), markers (fiducial markers, vaginal markers and rectal marker), immobilization system, head rest, cushions, spacers & wedges, arm & wrist support, locating & indexing bar and bite positioners
By End-User:
The industry is classified by end user as hospitals, cancer research institutes and radiation/proton therapy centres
By Region:
Key countries such as Germany, Italy, France, UK, Spain, BENELUX, Russia and Rest of Europe have been covered in the report.
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain:
The global patient positioning system market size have the potential to expand significantly, with a CAGR of 5.4% from 2024 to 2034. The global patient positioning system market size is expected to be valued at USD 508.4 million by 2024. By 2034, the demand for patient positioning systems is expected to garner a significant valuation of USD 857.4 million.
The global radiotherapy patient positioning accessories market share is expected to record a CAGR of 4.8% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of USD 619.5 million. By 2033, the valuation is anticipated to reach USD 993.6 million.
The global nonvascular interventional radiology device market demand is likely to adhere to a CAGR of 4.9%. The ecosystem is likely to get elevated from USD 27.6 billion in 2024 to the valuation mark of USD 44.6 billion by 2034.
The global next-generation titrator market growth is expected to reach USD 7,171.9 million by 2034, owing to a moderate CAGR of 6.5% through the forecast period. The competitive space was measured at USD 3,820.6 million in 2024.
The global pressure infusion cuffs market trends is estimated to ascend at a valuation of approximately USD 350.8 million by 2024 as per Future Market Insights report. The change in industry valuation for the pressure infusion cuffs is likely to be at a moderate CAGR of 5.7% through 2034. The change in value in the ecosystem is estimated to reach a value of USD 610.7 million by the end of the forecast period.
The global infusion pump market outlook is estimated to be worth USD 4,932.2 million in 2024 and anticipated to reach a value of USD 8,345.4 million by 2034. Sales are projected to rise at a CAGR of 5.4% over the forecast period between 2024 and 2034.
The global platelet rich plasma market overview is estimated to be worth USD 444.4 million in 2024 and anticipated to reach a value of USD 1,163.1 million by 2034. Sales are projected to rise at a CAGR of 10.1% over the forecast period between 2024 and 2034.
The global bioimpedance devices market sales is estimated to be worth USD 650.5 million in 2024 and anticipated to reach a value of USD 1,244.2 million by 2034. Sales are projected to rise at a CAGR of 6.7% over the forecast period between 2024 and 2034.
The global small molecule API market forecast are estimated to be worth USD 120,376.6 million in 2024 and are anticipated to reach a value of USD 186,941.2 million by 2034. Sales are projected to rise at a CAGR of 4.5% over the forecast period between 2024 and 2034.
The veterinary vaccines market opportunity is estimated to reach USD 9,433.9 million in 2024. It is estimated that revenue will increase at a CAGR of 5.2% between 2024 and 2034. The industry is anticipated to reach USD 15,632.4 million by 2034.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube